It’s no secret that many primary care practices are capping out with the number of patients they can handle, forcing some providers to close their panels to new patients. Practices that are still accepting patients may require a waiting time of...
Azara Healthcare is pleased to report that the Azara DRVS reporting and analytics platform has received certification for Meaningful Use Stage 1 and Stage 2 measures from the Office of the National Coordinator for Health IT (ONC), an achievement...
Hello everyone.
A belated Happy New Year. Somehow it’s already mid-March, we have moved the clocks ahead, spring is on the horizon, and we finally can see bare ground again here in Boston after a long winter of snow, cold and more snow. After...
Thanks to everyone who weighed in on their top Clinical Quality Measures reporting priorities for 2014. We received a great response. As you can see, Meaningful Use finished as the top of the list, but there is plenty of interest in several other...
The arrival of 2014 and Meaningful Use Stage 2 means some significant changes to the Eligible Professional (EP) Clinical Quality Measures (CQMs), and providers must begin using the new measures regardless of what stage of Meaningful Use they are in.
"Apples to apples" is a common phrase used to describe a fair comparison between different items, and one that is particularly important in healthcare data. As Heather Budd, vice president of clinical transformation at Azara Healthcare explains in...
